Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for MIR.V.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
April 30, 2026 -24.52M
January 31, 2026 -24.03M
October 31, 2025 -23.37M
July 31, 2025 -22.56M
April 30, 2025 -21.52M
January 31, 2025 -20.54M
October 31, 2024 -19.34M
July 31, 2024 -18.04M
April 30, 2024 -16.86M
January 31, 2024 -16.08M
October 31, 2023 -15.81M
July 31, 2023 -15.03M
April 30, 2023 -14.07M
January 31, 2023 -13.48M
October 31, 2022 -12.99M
July 31, 2022 -12.36M
April 30, 2022 -11.89M
January 31, 2022 -11.48M
October 31, 2021 -16.22M
July 31, 2021 -15.72M
April 30, 2021 -15.59M
January 31, 2021 -15.25M
October 31, 2020 -14.85M
July 31, 2020 -15.56M
April 30, 2020 -15.29M
Date Value
January 31, 2020 -14.60M
October 31, 2019 -13.99M
July 31, 2019 -13.52M
April 30, 2019 -13.06M
January 31, 2019 -12.54M
October 31, 2018 -11.91M
July 31, 2018 -11.40M
April 30, 2018 -10.90M
January 31, 2018 -10.25M
October 31, 2017 -9.539M
July 31, 2017 -8.984M
April 30, 2017 -8.439M
January 31, 2017 -7.687M
October 31, 2016 -7.675M
July 31, 2016 -7.662M
April 30, 2016 -5.800M
January 31, 2016 -4.586M
October 31, 2015 -3.630M
July 31, 2015 -7.704M
April 30, 2015 -7.406M
January 31, 2015 -7.676M
October 31, 2014 -6.639M
July 31, 2014 -6.690M
April 30, 2014 -6.514M
January 31, 2014 -5.296M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
MedX Health Corp. -10.70M
VentriPoint Diagnostics Ltd. -4.117M
Theralase Technologies, Inc. 1.950M
Profound Medical Corp. 70.67M
VVT Med, Inc. -3.26M

Shareholders Equity (Quarterly) Related Metrics